BBS7 Antibodies

Santa Cruz Biotechnology offers a broad range of BBS7 monoclonal antibodies for research focused on understanding BBS7's role in cellular processes. BBS7 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BBS7, a member of the Bardet-Biedl syndrome (BBS) protein family, plays a crucial role in ciliary function and cellular signaling pathways. BBS7 is involved in the assembly and maintenance of cilia, which are essential for various physiological processes, including sensory perception and signaling. Research has shown that mutations in BBS7 can lead to Bardet-Biedl syndrome, a genetic disorder characterized by obesity, retinal degeneration, and polydactyly. Understanding BBS7's molecular mechanisms and interactions is vital for advancing our knowledge of ciliary biology and related disorders. Investigating BBS7's role in development and disease progression can provide new perspectives on potential therapeutic strategies. BBS7 monoclonal antibodies enable researchers to explore cellular pathways and protein interactions with exceptional specificity. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by facilitating precise and reliable research in the field of ciliary biology and genetic disorders.